Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$269.08M$269.08Mderived+12.2% vs Q4 2024 Net Income$136.09M$136.09Mderived+286.4% vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$233,006,000+14.4% Operating Incomederived$46,111,000+44.6% Operating Cash Flowderived$52,469,000−24.2% Free Cash Flowderived$41,813,000−32.7% Margins · derivedGross margin86.6%+1.6 pt vs Q4 2024
Operating margin17.1%+3.8 pt vs Q4 2024
Net margin50.6%+35.9 pt vs Q4 2024
ended Dec 31, 2025 · filed Feb 13, 2026 · 44 d after period end